[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603116":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":39,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":7,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":7,"briefSummary":50,"conditions":61,"keywords":66,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BIOLOGICAL","Biologic Agent","Intervention with biologic agents",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Nisar P Malek, Prof. Dr.","CONTACT","+4970712982722","zpm-meb@med.uni-tuebingen.de",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"University Hospital of Tübingen - Center for Personalized Medicine","RECRUITING","Tübingen","72076","Germany","DE",{"type":28,"coordinates":29},"Point",[30,31],9.05222,48.52266,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":36,"phoneExt":7,"email":18},"Fee Schmitt, Dr.","+4970712981240",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[40,42,44],{"name":41,"class":6},"University Hospital Freiburg",{"name":43,"class":6},"University Hospital Heidelberg",{"name":45,"class":6},"University Hospital Ulm","100603116","molecular-inflammation-board-at-the-center-for-personalized-medicine-100603116",false,"NCT07132333","Molecular Inflammation Board at the Center for Personalized Medicine","The Molecular Inflammation Board at the Centers for Personalized Medicine at the University Hospitals of Freiburg, Heidelberg, Tübingen and Ulm - A Multicenter Prospective Observational Study","MEB@ZPM","Inclusion Criteria:\n\n* Chronic inflammatory disorder (PsO, PsA, SpA, IBD)\n* Given informed consent\n* 18 years of age\n\nExclusion Criteria:\n\n* No capacity to consent","ALL","18 Years",{"count":57,"type":58},3000,"ESTIMATED","14 Months","OBSERVATIONAL",[62,63,64,65],"Psoriasis (PsO)","Psoriasis Arthritis","Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)","Spondylarthropathies",[67,68],"chronic inflammatory diseases","personalized medicine","2025-08-19",{"date":71,"type":72},"2025-08-20","ACTUAL",{"date":74,"type":72},"2022-11-16",{"date":76,"type":58},"2032-11",{"name":5,"class":6},1]